Literature DB >> 10836523

TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis.

J K Lacki1, R Moser, I Korczowska, S Mackiewicz, W Muller.   

Abstract

The present study was undertaken in order to investigate the relationship between tumor necrosis factor-alpha (TNF-alpha) gene polymorphism and the radiological progression of rheumatoid arthritis (RA) within the first 3-years of the disease. Sixty-eight RA patients (59 women and nine men) were observed for 3-years. TNF-alpha polymorphism analysis was performed in all patients. Radiographs of the hands were taken at the onset of study and after 3-years of follow-up. Radiographs were assessed according to the Larsen index (damage score and progression of damage score). We did not observe any correlation between TNF gene polymorphism and damage score or progression of damage score. The obtained data suggests that TNF-308 polymorphism cannot serve as an indicator of the disease course in RA patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836523     DOI: 10.1007/s002960050117

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  Tumor necrosis factor (TNF) and TNFR1 polymorphisms are not risk factors for rheumatoid arthritis in a Mexican population.

Authors:  Daniel Cadena-Sandoval; Isidro Alemán-Ávila; Rosa Elda Barbosa-Cobos; Lizbeth Teresa Becerril-Mendoza; José Manuel Fragoso; Julián Ramírez-Bello
Journal:  Mol Biol Rep       Date:  2018-02-05       Impact factor: 2.316

2.  Cytogenetic microarray in structurally normal and abnormal foetuses: a five year experience elucidating increasing acceptance and clinical utility.

Authors:  Meenakshi Lallar; Priyanka Srivastava; Archana Rai; Deepti Saxena; Kausik Mandal; Shubha R Phadke
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

Review 3.  Rheumatoid arthritis susceptibility genes: An overview.

Authors:  Izabela Korczowska
Journal:  World J Orthop       Date:  2014-09-18

4.  Tumour necrosis factor a -308 promoter polymorphism in patients with rheumatoid arthritis.

Authors:  Zahra Rezaieyazdi; Jalil Tavakol Afshari; Mahnaz Sandooghi; Farnaz Mohajer
Journal:  Rheumatol Int       Date:  2007-08-29       Impact factor: 2.631

5.  Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population.

Authors:  Petr Nemec; Monika Pavkova-Goldbergova; Martina Stouracova; Anna Vasku; Miroslav Soucek; Jindra Gatterova
Journal:  Clin Rheumatol       Date:  2007-06-12       Impact factor: 2.980

Review 6.  Association between TNF-α promoter -308 A/G polymorphism and rheumatoid arthritis: a meta-analysis.

Authors:  Gwan Gyu Song; Sang-Cheol Bae; Jae-Hoon Kim; Young Ho Lee
Journal:  Rheumatol Int       Date:  2013-12-05       Impact factor: 2.631

7.  Investigation of association between the TRAF family genes and RA susceptibility.

Authors:  Catherine Potter; Stephen Eyre; Andrew Cope; Jane Worthington; Anne Barton
Journal:  Ann Rheum Dis       Date:  2007-02-02       Impact factor: 19.103

8.  The contribution of four immunogenetic markers for predicting persistent activity in patients with recent-onset rheumatoid arthritis or undifferentiated arthritis.

Authors:  Sonsoles Reneses; Antonio Fernández-Suárez; Maria F González-Escribano; Luis Pestana; Alicia García
Journal:  ISRN Rheumatol       Date:  2011-08-08

9.  Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis.

Authors:  A Barton; H Platt; F Salway; D Symmons; E Barrett; M Bukhari; M Lunt; E Zeggini; S Eyre; A Hinks; D Tellam; B Brintnell; W Ollier; J Worthington; A Silman
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

10.  Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis.

Authors:  Erik J M Toonen; Pilar Barrera; Jaap Fransen; Arjan P M de Brouwer; Agnes M Eijsbouts; Pierre Miossec; Hubert Marotte; Hans Scheffer; Piet L C M van Riel; Barbara Franke; Marieke J H Coenen
Journal:  Arthritis Res Ther       Date:  2012-12-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.